Vol 8, Supplement 1 (January 2019): Translational Cancer Research (Targeted Therapy and Non-Small Cell Lung Cancer: A New Era?)

Original Article

Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform
Clara Mayo de las Casas, Mónica Garzón-Ibañez, Núria Jordana-Ariza, Santiago Viteri-Ramírez, Irene Moya-Horno, Niki Karachaliou, Zaira Yeste, Raquel Campos, Sergi Villatoro, Ariadna Balada-Bel, Beatriz García-Peláez, Noemí Reguart, Cristina Teixidó, Eloisa Jantús, Silvia Calabuig, Cristina Aguado, Ana Giménez-Capitán, Ruth Román-Lladó, Ana Pérez-Rosado, Maria José Catalán, Jordi Bertrán-Alamillo, Silvia García-Román, Sonia Rodriguez, Lidia Alonso, Erika Aldeguer, Alejandro Martínez-Bueno, Maria González-Cao, Andrés Aguilar Hernandez, Juan Garcia-Mosquera, Maria de los Llanos Gil, Manuel Fernandez, Rafael Rosell, Miguel Ángel Molina-Vila
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology
Claudia Yvonne Finocchiaro, Alessandra Rota, Vito Barbieri, Anna Bettini, Roberto Bianco, Gloria Borra, Lucio Buffoni, Alessandra Bulotta, Annamaria Carta, Diego Cortinovis, Raffaele Costanzo, Antonio Cusmai, Romano Danesi, Ettore D’Argento, Alessandro Del Conte, Tindara Franchina, Marina Gilli, Vanesa Gregorc, Luciana Irtelli, Lorenza Landi, Francesco Malorgio, Gianfranco Mancuso, Olga Martelli, Paola Mazzanti, Barbara Melotti, Maria Rita Migliorino, Vincenzo Minotti, Michele Montrone, Alessandro Morabito, Elisa Roca, Giampiero Romano, Antonio Rossi, Giuseppa Savio, Marcello Tiseo, Ivano Boscardini, Lorenzo Piccolo, Sara Pilotto, Umberto Malapelle

Review Article

EGFR first- and second-generation TKIs—there is still place for them in EGFR-mutant NSCLC patients
Niki Karachaliou, Manuel Fernandez-Bruno, Jillian Wilhelmina Paulina Bracht, Rafael Rosell
Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer
Tiziana Vavalà, Annapaola Mariniello, Silvia Novello
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
Angela Listì, Nadia Barraco, Marco Bono, Lavinia Insalaco, Luisa Castellana, Sofia Cutaia, Maria Rita Ricciardi, Valerio Gristina, Enrico Bronte, Gianni Pantuso, Francesco Passiglia

Case Report

EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review
Pasquale Pisapia, Danilo Rocco, Francesco Pepe, Caterina De Luca, Ciro Battiloro, Riccardo Smeraglio, Miriam Cieri, Claudio Bellevicine, Giancarlo Troncone, Umberto Malapelle

Editorial

Immunotherapy as a targeted therapy in non-small cell lung cancer
Danilo Rocco, Luigi Della Gravara, Aniello Avellino, Vincenzo Montesarchio, Ciro Battiloro

Perspective

EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy
Pablo Reclusa, Jean-François Laes, Umberto Malapelle, Anna Valentino, Danilo Rocco, Ignacio Gil-Bazo, Christian Rolfo